NCT02210442 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Del Cura-González I, López-Rodríguez JA, Sanz-Cuesta T, Rodríguez-Barrientos R, Martín-Fernández J, Ariza-Cardiel G, Polentinos-Castro E, Román-Crespo B, Escortell-Mayor E, Rico-Blázquez M, Hernández-Santiago V, Azcoaga-Lorenzo A, Ojeda-Ruiz E, González-González AI, Ávila-Tomas JF, Barrio-Cortés J, Molero-García JM, Ferrer-Peña R, Tello-Bernabé ME, Trujillo-Martín M; Educaguia Group
Effectiveness of a strategy that uses educational games to implement clinical practice guidelines among Spanish residents of family and community medicine (e-EDUCAGUIA project): a clinical trial by clusters. Implement Sci. 2016 May 17;11:71. doi: 10.1186/s13012-016-0425-3.

Educaguia Project: Clinical Trial, Randomised by Clusters, to Assess the Effectiveness of a Strategy With Educational Games to Implementation pf Clinical Practice Guidelines to Family Medicine Residents in Spain.

Details for clinical trial NCT02210442

Clinical trial NCT02210442 - References